Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019

Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019

Bibliographic Details
Main Authors:	Chengshui Chen, Feng Qi, Keqing Shi, Yuping Li, Ji Li, Yongping Chen, Jingye Pan, Tieli Zhou, Xiangyang Lin, Jinsan Zhang, Yongde Luo, Xiaokun Li, Jinglin Xia
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.35

Similar Items

Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study
by: Yuping Li, et al.
Published: (2021-02-01)

High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis
by: Hong-xia Xue, et al.
Published: (2015-01-01)

Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial
by: Yuan-Yuan Qin, et al.
Published: (2020-05-01)

Successful treatment with thalidomide for pemphigus vulgaris
by: Bingjie Zhang, et al.
Published: (2020-05-01)

Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone
by: Petra Bělohlávková, et al.
Published: (2016-08-01)

Radiomics Is Effective for Distinguishing Coronavirus Disease 2019 Pneumonia From Influenza Virus Pneumonia
by: Liaoyi Lin, et al.
Published: (2021-06-01)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
by: Hua-Hao Fan, et al.
Published: (2020-05-01)

Treatment of Aphthae with Thalidomide
by: Mahmoud Farshchian
Published: (1994-03-01)

Thalidomide in dermatology: Revisited
by: Iffat Hassan, et al.
Published: (2015-01-01)

Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19
by: Hai-Yan Fu, et al.
Published: (2020-01-01)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
by: Wei Cao, et al.
Published: (2021-02-01)

Feasibility of coronavirus disease 2019 eradication
by: Ya-Li Zheng, et al.
Published: (2020-06-01)

Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
by: Yaocheng Chen, et al.
Published: (2020-07-01)

Curative effect of small-dose glucocorticoids + azithromycin treatment of lobar pneumonia
by: Li Zhang
Published: (2018-12-01)

Coronavirus disease 2019 in pregnancy
by: Xu Qiancheng, et al.
Published: (2020-06-01)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
by: Wei Cao, et al.
Published: (2021-03-01)

Focus on coronavirus disease 2019 associated coagulopathy
by: Xiang-Hong Yang, et al.
Published: (2020-09-01)

Prevention and management of thalidomide toxicity
by: Bhavana Ravindra Doshi, et al.
Published: (2017-01-01)

Rasmussen Syndrome: Response to Thalidomide
by: J Gordon Millichap
Published: (2003-11-01)

Forgive sins: rise of thalidomide
by: Yugandar Inakanti, et al.
Published: (2014-04-01)

Leukocytoclastic vasculitis due to thalidomide
by: Asude Kara, et al.
Published: (2017-03-01)

Pharmacokinetic study of thalidomide in rabbits
by: 陳紀元
Published: (2003)

Changes in the Clinical Characteristics of 62 Patients Who Died from Coronavirus Disease 2019
by: Jingli Chen, et al.
Published: (2020-01-01)

Safety and tolerability of high doses of glucocorticoides
by: Rakić Branislava D., et al.
Published: (2016-01-01)

Expression of proteins and anticancer effect of thalidomide in bladder cancer cells
by: Hsiao-li Lin, et al.
Published: (2006)

Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling
by: Sora Yasri, et al.
Published: (2020-01-01)

Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study
by: Wenxin Hong, et al.
Published: (2020-11-01)

Clinical value of blood markers to assess the severity of coronavirus disease 2019
by: Liu-Niu Xiao, et al.
Published: (2021-09-01)

Thalidomide for the treatment of angiodysplasia‐related recurrent gastrointestinal hemorrhage: Is low dose a safe and viable option?
by: Harish Patel, et al.
Published: (2019-12-01)

Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
by: Taleb Azarm, et al.
Published: (2012-01-01)

Physics, chemistry, and Hirshfeld surface analyses of gamma-irradiated thalidomide to evaluate behavior under sterilization doses
by: Valner A.F.S.N. Mussel, et al.
Published: (2018-06-01)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
by: Tong Li, et al.
Published: (2020-11-01)

Thalidomide surveillance and pharmacovigilance in Brazil – an overview
by: Lisiane Freitas Leal, et al.
Published: (2020-11-01)

The place of thalidomide in the treatment of multiple myeloma
by: Alessandro Corso, et al.
Published: (2011-12-01)

The place of thalidomide in the treatment of multiple myeloma
by: Alessandro Corso, et al.
Published: (2011-12-01)

Molecular Mechanisms of the Teratogenic Effects of Thalidomide
by: Tomoko Asatsuma-Okumura, et al.
Published: (2020-05-01)

Thalidomide-induced Bradycardia in an Old Man
by: Ching-Hsueh Tseng, et al.
Published: (2010-12-01)

Hailey-Hailey disease responding to thalidomide
by: K Bala Nanda, et al.
Published: (2014-01-01)

Thalidomide in treatment of connective diseases and vasculities
by: D. Ribatti, et al.
Published: (2011-09-01)

Thalidomide-induced leukocytoclastic vasculitis in leprosy
by: Vasudha Abhijit Belgaumkar, et al.
Published: (2019-01-01)